Comments are Off
The Board of Directors of the Nubbo Incubator (formerly Midi-Pyrénées Incubator) has given its approval for the support of GENOSKIN project.
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
Shop – Europe & Middle-East
Shop – Asia & Pacific
Shop – United States & Canada
Genoskin CSO obtains high-profile career award
4 January 2022
Better Technology for Reliable Drug Development
3 January 2022
Genoskin launches spatial skin biology platform MANTIS®
6 December 2021
Dr. Nicolas Gaudenzio is appointed Chief Scientific Officer at Genoskin
8 November 2021